Cure My Disease

Don't miss your cure!

 Log in / Sign up

Fasting during chemo: a new weapon against breast cancer?

NCT ID NCT07440784

Ongoing Disease control Sponsor: Khyber Medical University Peshawar Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether adding intermittent or water-only fasting to standard chemotherapy can improve outcomes for breast cancer patients. Sixty women will be split into four groups: chemo alone, chemo plus intermittent fasting, chemo plus intermittent fasting with a ketogenic diet, or chemo plus a two-week water-only fast. Researchers will measure tumor markers, immune cell counts, inflammation, and quality of life to see if fasting helps the body fight cancer better and handle treatment more easily.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
intermittent fasting (23:1 regimen) and water-only fasting
What this could lead to
If it works, this could point toward a simple, low-cost way to boost chemotherapy effectiveness and reduce side effects for breast cancer patients.
What could go wrong
This is a small, early-phase trial with only 60 participants. Fasting may be hard to stick with, and results may not apply to all patients. It is not a cure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm Intermittent Fasting

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CANCER

Contacts and locations

Locations

  • Institute of Nuclear Medicine Oncology & Radiotherapy (INOR)

    Abbottābād, Khyber Pakhtunkhwa, 22010, Pakistan

More trials for these conditions

Other studies related to the condition(s) this trial covers.